32 results on '"Thomas T. MacDonald"'
Search Results
2. Interferon-gamma-expressing cells are a major source of interleukin-21 in inflammatory bowel diseases
3. P105 Human neutrophil elastase degrades the therapeutic monoclonal antibodies effective in IBD
4. CC-10004 but not thalidomide or lenalidomide inhibits lamina propria mononuclear cell TNF-α and MMP-3 production in patients with inflammatory bowel disease
5. P032 The pharmacological profile of TOP1288, a narrow spectrum kinase inhibitor in clinical development as an anti-inflammatory treatment for ulcerative colitis
6. Bacterial Regulation of Intestinal Immune Responses
7. Proteolytic enzymes in inflammatory bowel disease
8. Intestinal cytokines in inflammatory bowel disease and invasive diarrhoea
9. Ontogeny and induction of adhesion molecule expression in human fetal intestine
10. Tumour necrosis factor-alpha and interferon-gamma production measured at the single cell level in normal and inflamed human intestine
11. P066 Human intestinal Vδ2+ T-cells promote mucosal inflammation in Crohn's disease and are selectively ablated by azathioprine therapy
12. P020 Interleukin-17A but not interleukin-17E is profibrotic in the gut of patients with Crohn's disease
13. P054 Interactions between neutrophil elastase and biologics in IBD
14. P053 Interleukin-17A homodimer reduces pro-inflammatory cytokine production by inflammatory bowel disease mucosa cultured ex vivo
15. P002 Intestinal homeostasis is critically regulated by the transcription factor T-bet
16. P073 Ex vivo activation of triggering receptor expressed on myeloid cells 1 enhances the production of pro-inflammatory cytokines by inflammatory bowel disease mucosa
17. P019 The role of human neutrophil elastase and its inhibitor elafin in ulcerative colitis
18. P057 Micro-RNA expression profiling identifies miR-29b as a relevant pro-fibrogenic factor in Crohn's disease intestinal strictures
19. P036 Involvement of gut macrophages in the fibrogenic process in Crohn's disease
20. P037 Is ulcerative colitis an atypical Th2-mediated disease characterised by excess production of interleukin-13?
21. S28 T-regulatory cells in Crohn's disease patients treated with infliximab
22. O11 CURCUMIN SUPPRESSES P38 MAPK ACTIVATION, REDUCES IL-1BETA AND MMP-3, AND ENHANCES IL-10 EXPRESSION IN THE MUCOSA OF PATIENTS WITH INFLAMMATORY BOWEL DISEASE
23. P294 - Control of interleukin-17 production in inflammatory bowel disease
24. P270 - Fibroblast activation protein expression in Crohn's disease strictures
25. P267 - Smad7 controls resistance of colitogenic T cells to regulatory T cell-mediated suppression
26. 2 - Targeting gut T cell Ca2+ release-activated Ca2+ channels inhibits Th1 cytokine production and T-box transcription factor T-bet in inflammatory bowel disease
27. P272 EFFECT OF INFLIXIMAB ON CD4+CD25HIGHFOXP3+ T-REGULATORY CELLS IN CROHN'S DISEASE
28. P256 THE ENDOCANNABINOID SYSTEM IN INFLAMMATORY BOWEL DISEASE
29. P027 FUNCTIONAL MODULATION OF CROHN'S DISEASE MYOFIBROBLASTS BY ANTI-TNF ANTIBODIES
30. Regulation of Matrix Metalloproteinases Synthesis by Interleukin-21 in Human Intestinal Fibroblasts
31. Transforming Growth Factor-β Signaling and Matrix Metalloproteinase Pattern in Intestinal Strictures in Crohn's Disease
32. Matrix Metalloproteinases in Gut Injury
Catalog
Books, media, physical & digital resources
Discovery Service for Jio Institute Digital Library
For full access to our library's resources, please sign in.